A Tale of Two Centers: International Comparison Reveals US Shortcomings in Clinical Trial Enrollment

Elsevier Global Medical News. 2009 Aug 24, R Finn

SAN FRANCISCO (EGMN) - Virtually every step in the process of taking a clinical trial from submission of documents to patient accrual took significantly longer at a tertiary care medical center in the United States than at a similar institution in Europe, according to a study that compared thoracic oncology trials at Washington University in St. Louis to those at the University of Turin in Italy.The U.S. trials also lagged in patient enrollment, although this was a problem at both institutions. Investigators...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration